p16 overexpression identifies oncogenic high‐risk HPV infection in non‐oropharyngeal squamous cell carcinoma of the head and neck

Documents similaires

• Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1–T2 HPV Negative oropharyngeal squamous cell carcinoma
  par: Francisco Laxague, et autres
  Publié: (2024)
• Establishment of an in situ model to explore the tumor immune microenvironment in head and neck squamous cell carcinoma
  par: Congxian Lu, et autres
  Publié: (2024)
• The impact of COVID‐19 and vaccination status on outcomes in veterans with head and neck squamous cell carcinoma
  par: James D. Johns, et autres
  Publié: (2024)
• Acute and definitive management of oropharyngeal hemorrhage in patients with squamous cell carcinoma of the oropharynx
  par: Ana V. Araujo, et autres
  Publié: (2024)
• Pretreatment fat‐free mass index correlates with early death in patients with head and neck squamous cell carcinoma
  par: Charbél Talani, et autres
  Publié: (2024)